GENE Nasdaq

Genetic Technologies Ltd

GENE | News | $2.26 -4.64% -4.87% 18K

(0.0% 1d) (-7.4% 1m) (117.4% 1y) (0.0% 2d) (0.0% 3d) (-25.0% 7d) (-63.29% volume)
Earnings Calendar:
Market Cap: $ 8,694,767
http://www.gtglabs.com
Sec Filling | Patents | 56 employees

(AU) Genetic Technologies Ltd. is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. It operates through the USA and Australia geographical segments. The firm's product BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.

breast cancer cancer molecular diagnostics women health genetic women diagnostics

add to watch list Paper trade email alert is off

Press-releases

Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
Published: 2024-04-22 (Crawled : 19:00) - globenewswire.com
GENE | News | $2.26 -4.64% -4.87% 18K

Health Technology

| Email alert Add to watchlist
GNTLF | News | $0.0007 1185.71% 2K

n/a

| Email alert Add to watchlist
genetic million direct offering

Genetic Technologies Announces $2 Million Registered Direct Offering
Published: 2024-04-18 (Crawled : 16:00) - globenewswire.com
GENE | News | $2.26 -4.64% -4.87% 18K

Health Technology

| -25.0% | O: -0.32% H: 1.59% C: -22.54%
genetic million direct offering

New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
GENE | News | $2.26 -4.64% -4.87% 18K

Health Technology

| -25.24% | O: 3.47% H: 0.0% C: -3.66%
precision treatment

GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
GENE | News | $2.26 -4.64% -4.87% 18K

Health Technology

| -27.53% | O: -0.0% H: 0.92% C: -3.06%
sales year growing

GTG to pilot GeneType in Breast Screen centers across the U.S.
Published: 2024-04-11 (Crawled : 12:00) - globenewswire.com
GENE | News | $2.26 -4.64% -4.87% 18K

Health Technology

| -19.11% | O: 4.1% H: 4.92% C: 4.92%
breast pilot

EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
GENE | News | $2.26 -4.64% -4.87% 18K

Health Technology

| -15.96% | O: 1.77% H: 0.0% C: -0.35%
health women

Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
GENE | News | $2.26 -4.64% -4.87% 18K

Health Technology

| -16.25% | O: 4.24% H: 0.0% C: -8.14%
genetic market

GTG Global Collaborations and Innovation Update
Published: 2024-03-26 (Crawled : 12:00) - globenewswire.com
GENE | News | $2.26 -4.64% -4.87% 18K

Health Technology

| -7.42% | O: -1.17% H: 7.11% C: 7.11%
innovation update global

GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
GENE | News | $2.26 -4.64% -4.87% 18K

Health Technology

| -11.24% | O: 1.12% H: 1.85% C: -5.19%
test risk advanced

GTG to launch U.S. Customer Digital Media Sales Campaign
Published: 2024-02-28 (Crawled : 13:00) - globenewswire.com
GENE | News | $2.26 -4.64% -4.87% 18K

Health Technology